IL1B and atherosclerosis: TMAO drives atherosclerosis progression [110], in part, by regulating macrophage activation and foam cell formation, platelet activation, and aggregation, resulting in elevated expression of IL-1β, IL-6, and TNFα inflammatory cytokines [134].